Want to join the conversation?
Chris Bottiglieri of Wolfe Research asks about the distribution strategy. $AAP said it is looking at every aspect of the supply chain and the aim is to transform it and make it more customer-friendly in terms of delivery. $AAP will provide more details at a later time but currently it is taking a holistic approach to the supply chain.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.